Ellis Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Ellis Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14	Closed	-$7K	–	695
2022 Q3	$7K	Sell	14 -40	-74%	-$22.4K	﹤0.01%	631
2022 Q2	$29K	Hold	54	–	–	0.01%	458
2022 Q1	$31K	Hold	54	–	–	0.01%	466
2021 Q4	$36K	Hold	54	–	–	0.01%	464
2021 Q3	$30K	Buy	54 +40	+286%	+$22K	0.01%	461
2021 Q2	$7K	Hold	14	–	–	﹤0.01%	659
2021 Q1	$6K	Hold	14	–	–	﹤0.01%	649
2020 Q4	$7K	Sell	14 -25	-64%	-$11.7K	﹤0.01%	606
2020 Q3	$17K	Buy	39 +25	+179%	+$10.3K	0.01%	492
2020 Q2	$5K	Hold	14	–	–	﹤0.01%	617
2020 Q1	$3K	Buy	+14	New	+$4.42K	﹤0.01%	619

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellis Investment Partners's TMO Position: Q4 2022 in Review

Ellis Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 14 shares — an estimated $7K sold.

Ellis Investment Partners first reported a position in TMO in Q1 2020 and held it in 11 quarters. The position peaked at $36K in Q4 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Ellis Investment Partners reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
Ellis Investment Partners sold 14 Thermo Fisher Scientific shares in Q4 2022, an estimated $7K.
Ellis Investment Partners first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 11 quarters.
Ellis Investment Partners's Thermo Fisher Scientific position peaked at $36K in Q4 2021.
2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.